Yen‐Hou Chang

417 total citations
12 papers, 207 citations indexed

About

Yen‐Hou Chang is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Yen‐Hou Chang has authored 12 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 6 papers in Obstetrics and Gynecology and 5 papers in Surgery. Recurrent topics in Yen‐Hou Chang's work include Ovarian cancer diagnosis and treatment (5 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Endometriosis Research and Treatment (3 papers). Yen‐Hou Chang is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Endometriosis Research and Treatment (3 papers). Yen‐Hou Chang collaborates with scholars based in Taiwan, United States and United Kingdom. Yen‐Hou Chang's co-authors include Chi‐Mu Chuang, Kuan-Chong Chao, Pi‐Lin Sung, Chen-Hsin Albert Yu, Wendy W. Hwang‐Verslues, Peng‐Hui Wang, Teh‐Fu Hsu, Lingyu Jiang, Yi‐Jen Chen and Chia‐Hao Liu and has published in prestigious journals such as Cancer Research, The American Journal of Surgical Pathology and Cancer Letters.

In The Last Decade

Yen‐Hou Chang

12 papers receiving 207 citations

Peers

Yen‐Hou Chang
Yen‐Hou Chang
Citations per year, relative to Yen‐Hou Chang Yen‐Hou Chang (= 1×) peers Shujie Pang

Countries citing papers authored by Yen‐Hou Chang

Since Specialization
Citations

This map shows the geographic impact of Yen‐Hou Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen‐Hou Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen‐Hou Chang more than expected).

Fields of papers citing papers by Yen‐Hou Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yen‐Hou Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen‐Hou Chang. The network helps show where Yen‐Hou Chang may publish in the future.

Co-authorship network of co-authors of Yen‐Hou Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Yen‐Hou Chang. A scholar is included among the top collaborators of Yen‐Hou Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yen‐Hou Chang. Yen‐Hou Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Jiang, Lingyu, et al.. (2023). Robot-assisted sacrohysteropexy vs robot-assisted sacrocolpopexy in women with primary advanced apical prolapse: A retrospective cohort study. Journal of the Chinese Medical Association. 86(4). 418–425. 2 indexed citations
2.
Yu, Chen-Hsin Albert, et al.. (2022). MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis. Cancer Research. 83(2). 251–263. 61 indexed citations
3.
Hsu, Teh‐Fu, et al.. (2022). Comparison of the O-RADS and ADNEX models regarding malignancy rate and validity in evaluating adnexal lesions. European Radiology. 32(11). 7854–7864. 22 indexed citations
4.
Hsu, Teh‐Fu, et al.. (2022). Maintenance Therapy for Preventing Endometrioma Recurrence after Endometriosis Resection Surgery – A Systematic Review and Network Meta-analysis. Journal of Minimally Invasive Gynecology. 29(5). 602–612. 13 indexed citations
5.
Hsu, Teh‐Fu, et al.. (2022). Maintenance dienogest therapy following adjuvant gonadotropin‐releasing hormone agonist treatment after uterus‐sparing surgery in adenomyosis: A retrospective cohort study. International Journal of Gynecology & Obstetrics. 161(3). 751–759. 5 indexed citations
6.
Lin, Shih‐Yao, et al.. (2022). Loss of Major Histocompatibility Complex Class I, CD8+ Tumor-infiltrating Lymphocytes, and PD-L1 Expression in Ovarian Clear Cell Carcinoma. The American Journal of Surgical Pathology. 47(1). 124–130. 8 indexed citations
7.
Hsu, Teh‐Fu, et al.. (2022). Maintenance Therapy for Preventing Endometrioma Recurrence After Endometriosis Resection Surgery—A Systematic Review and Network Meta-analysis. Obstetrical & Gynecological Survey. 77(6). 339–340. 2 indexed citations
9.
10.
Shen, Yao, Changsheng Liu, Yen‐Hou Chang, et al.. (2015). Subtype-specific binding peptides enhance the therapeutic efficacy of nanomedicine in the treatment of ovarian cancer. Cancer Letters. 360(1). 39–47. 5 indexed citations
11.
Horng, Huann‐Cheng, et al.. (2014). Prognostic factors of primary fallopian tube cancer in a single institute in Taiwan. International Journal of Gynecology & Obstetrics. 127(1). 77–81. 9 indexed citations
12.
Sung, Pi‐Lin, Yen‐Hou Chang, Kuan-Chong Chao, & Chi‐Mu Chuang. (2014). Global distribution pattern of histological subtypes of epithelial ovarian cancer: A database analysis and systematic review. Gynecologic Oncology. 133(2). 147–154. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026